1. CP-014 Trabectedin plus pegylated liposomial doxorubicin in relapsed ovarian cancer: outcomes in award-treated patients and Platinum Free Interval. (24th February 2014) Authors: Bellavia, G; Scorsone, C; Cascone, V; Rizza, G Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CP-015 Skin toxicity as an early predictor of effectiveness in patients with colon cancer treated with cetuximab. (24th February 2014) Authors: Bellavia, G; Scorsone, C; Cascone, V; Rizza, G Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CP-045 Over level progression free survival of azacitidine in myelodysplastic syndrome and in acute myeloid leukaemia. (25th February 2017) Authors: Cascone, V; Distefano, G; Zampogna, L; Poidomani, M; Antolino, A; Garozzo, G; Rizza, G; Drago, G Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DD-005 COBUS clinical audit: a vehicle to improve prescribing of albumin. (24th February 2014) Authors: Caruso, F; Cascone, V; Meli, S; Rizza, G Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DGI-020 Cost and Effectiveness of Targeted Treatment with Cetuximab or Bevacizumab as Maintenance Treatment in Patients with Colorectal Cancer. (12th March 2013) Authors: Rizza, G; Bellavia, G; Scorsone, C; Cascone, V Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DGI-076 Use of Colony Stimulating Factors (CSF-G) in Febrile Neutropenia in Patients Undergoing Cancer Chemotherapy. (12th March 2013) Authors: Cascone, V; Caruso, F; Sammatrice, D; Rizza, G Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DI-021 Lack of BCG for the treatment of bladder cancer: pharmacoeconomic and clinical impact. (24th February 2014) Authors: Cascone, V; Rizza, G; Smeriglio, A; Tomaino, A Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. GM-006 Monitoring of waiting times for anticancer chemotherapy as an indicator of quality performance. (14th February 2016) Authors: Cascone, V; Rizza, G; Garozzo, G; Antolino, A; Firrincieli, M; Caruso, F; Scorsone, C; Bellavia, G Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. TCH-015 Evaluation of the Chemical and Physical Stability of Sodium Dichloroacetate, an Orphan Drug For Rare Metabolic Diseases. (12th March 2013) Authors: Cascone, V; Tomaino, A; Florio, P; Cristani, M; Rizza, G Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗